Within a strategic framework, CEM will seek to enhance the international reputation that Queen’s University already has in ophthalmic research, particularly in the areas of retinal angiogenesis, diabetic retinopathy, age-related macular degeneration (AMD) and genetics. We are building on this foundation to develop complementary world-class vascular research, to include diabetic microvasculopathy and cardiovascular remodelling.
Our three research divisions are “Clinical & Experimental Ophthalmology”, “Diabetic Vascular Complications” and “Cardiovascular Remodelling" The research objectives of these divisions and the entire Centre are:
- To develop a multidisciplinary and integrated clinic and laboratory-based research programme in vision science and microvascular biology with well-considered quality thresholds for membership.
- To promote productive collaborative networks within the Centre/School and also with national and international partners.
- Establish multidisciplinary, self-sustaining programmes of research that promote individual and group success that have international recognition.
- To translate basic and clinical research discoveries into demonstrable and testable improvements in patient care in the Northern Ireland Hospital Trusts, and beyond.
- To train future clinical and scientific research leaders in vision and microvascular science.
- To promote the generation of scientific knowledge in key ophthalmic and microvascular diseases and share that knowledge with researchers, clinicians and the public through educational activities, training programmes and publications.
- To encourage commercialisation of research and develop strategic partnerships with biotech and pharmaceutical industrial collaborators.